Roberts Pharmaceutical Corp focuses on value-added specialty pharmaceuticals in the therapeutic areas of gastroenterology, urology, oncology/hematology, and cardiology/neurology. The Company identifies and acquires novel post-discovery drug candidates to advance through late-stage clinical development. Roberts operates in the United States, Canada, and the United Kingdom.
